Holly Brown, a certified medical assistant at ClearChoiceMD Urgent Care, in Brattleboro, Vt., draws blood during a COVID-19 antibody test on Saturday, May 16, 2020. AP
Antivirals, anti-inflammatory drugs and prepackaged plasma:
A look at the therapies being developed to combat the new coronavirus
THE OREGONIAN - Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed more than 312,000 people remains a long way off — and might never arrive.
Hundreds of COVID-19 treatment drugs are being studied and some doctors are skeptical that drugs for heartburn or hot flashes have any chance of treating a killer like COVID-19. Other experts say scientists should cast a wide net.
“I don’t think we want to rule anything out because it sounds out of the ordinary,” said Walid Gellad, assistant professor of health policy and management and director of Pitt’s Center for Pharmaceutical Policy and Prescribing.
Read article
Antivirals, anti-inflammatory drugs and prepackaged plasma: A look at the therapies being developed to combat the new coronavirus, posted May 18, 2020, by Kaiser Health News.
5/18/2020